Page 68 - Read Online
P. 68

Zavridis et al. J Cancer Metastasis Treat 2017;3:60-4                               Journal of
           DOI: 10.20517/2394-4722.2017.04
                                                             Cancer Metastasis and Treatment

                                                                                               www.jcmtjournal.com
            Original Article                                                                    Open Access


           Percutaneous, computed tomography

           guided neurolysis using continuous

           radiofrequency for pain reduction in

           oncologic patients



           Periklis Zavridis , Maria Tsitskari , Argyro Mazioti , Dimitrios Filippiadis 3
                                                      3
                                        2
                         1
           1 Department of Anaesthesiology and Pain Management, American Medical Center, Strovolos 2054, Nicosia, Cyprus.
           2 Department of Interventional Radiology, Apollonion Private Hospital, Strovolos 2054, Nicosia, Cyprus.
           3 2nd Radiology Department, University General Hospital “ATTIKON”, 12462 Athens, Greece.
           Correspondence to: Prof. Dimitrios Filippiadis, 2nd Radiology Department, University General Hospital “ATTIKON”, Medical School, National
           and Kapodistrian University of Athens, 1 Rimini Str., 12462 Athens, Greece. E-mail: dfilippiadis@yahoo.gr
           How to cite this article: Zavridis P, Tsitskari M, Mazioti A, Filippiadis D. Percutaneous, computed tomography guided neurolysis using continuous
           radiofrequency for pain reduction in oncologic patients. J Cancer Metastasis Treat 2017;3:60-4.
                                         ABSTRACT
            Article history:              Aim: This study evaluates the efficacy and safety of percutaneous computed tomography
            Received: 07-01-2017          (CT)-guided neurolysis using continuous radiofrequency for pain reduction in oncologic
            Accepted: 02-03-2017          patients. Methods: Over the course of 16 months, 22 patients underwent radiofrequency
            Published: 27-03-2017         neurolysis as palliative therapy for pain reduction in celiac and splachnic plexus (n = 9),
                                          thoracic (n = 1), lumbar (n = 2) and superior hypogastric plexus (n = 5), as well as stellate
            Key words:                    ganglion (n = 5). Pain levels before treatment, one week after treatment, and at the last
            Pain,                         follow-up (average follow-up 6 months) were compared by means of a Numeric Visual
            oncology,                     Scale (NVS) questionnaire and a Brief Pain Inventory (Short Form) questionnaire. Results:
            computed tomography,          Median procedure time was 44 min. Median number of CT scans, performed to control
            neurolysis,                   correct positioning of the cannula and precise electrode placement, was 8. Pain scores
            continuous radiofrequency
                                          of questionnaires prior to treatment (mean value 9.50 NVS units, range 8-10 NVS units)
                                          and post treatment (mean value 3.27 NVS units, range 2-6 NVS units) showed a mean
                                          decrease of 6.23 NVS units in terms of pain reduction and life quality improvement (P <
                                          0.05). Overall mobility improved in 18/18 (100%) patients. No complication was observed.
                                          Conclusion:  This  study  concludes  that CT-guided  neurolysis  by  means  of  continuous
                                          radiofrequency ablation is a safe and efficient technique for pain palliation in oncologic
                                          patients.

           INTRODUCTION                                       time of diagnosis, and nearly 80% of advanced stage
                                                              cancer patients report moderate to severe pain.
                                                                                                             [1]
           Approximately half of cancer patients report pain at the   Cancer pain can be classified as nociceptive (caused

                                                                                              Quick Response Code:
                       This is an open access article distributed under the terms of the Creative Commons Attribution-
                       NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work
            non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.


            For reprints contact: service@oaepublish.com

            60                                                                                                                                © 2017 OAE Publishing Inc.  www.oaepublish.com
   63   64   65   66   67   68   69   70   71   72   73